SCHEMBL3662655

SCHEMBL3662655

O=C(Nc1ccc2ccccc2c1)c1ccc(O)c(C(=O)O)c1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 12/20 0.65
▸ RAB9A P51151 12/20 0.65
▸ KMT2A Q03164 10/20 0.65
▸ MEN1 O00255 9/20 0.65
▸ DEGS1 O15121 1/20 0.61
▸ TDP1 Q9NUW8 1/20 0.59
▸ ALDH1A1 P00352 1/20 0.57
▸ PKM P14618 1/20 0.57
▸ CASP3 P42574 3/20 0.57
▸ SENP7 Q9BQF6 3/20 0.57
▸ L3MBTL1 Q9Y468 1/20 0.57
▸ KDM4E B2RXH2 1/20 0.57
▸ SENP6 Q9GZR1 1/20 0.57
▸ NQO2 P16083 1/20 0.56
▸ ACMSD Q8TDX5 1/20 0.56
▸ SIRT6 Q8N6T7 1/20 0.55
▸ NR1H4 Q96RI1 1/20 0.54
▸ ALOX15 P16050 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3661071 0.94 DEGS1 (0.65) NPC1RAB9AKMT2AMEN1DEGS1
SCHEMBL3657339 0.89 KMT2A (0.69) NPC1RAB9AKMT2AMEN1DEGS1
SCHEMBL3657251 0.86 KMT2A (0.74) NPC1RAB9AKMT2AMEN1DEGS1
SCHEMBL3654104 0.85 SIRT6 (0.59) KMT2AMEN1ALDH1A1PKMKDM4E
SCHEMBL3660083 0.82 NPC1 (0.74) NPC1RAB9AKMT2AMEN1DEGS1
SCHEMBL1129948 0.82 KMT2A (0.77) NPC1RAB9AKMT2AMEN1TDP1
SCHEMBL3503370 0.82 NPC1 (0.84) NPC1RAB9AKMT2AMEN1DEGS1
SCHEMBL7706007 0.81 TOP1 (0.62) KMT2AMEN1DEGS1TDP1PKM
SCHEMBL2229842 0.80 NPC1 (0.76) NPC1RAB9AKMT2AMEN1DEGS1
SCHEMBL10758235 0.80 SIRT6 (0.64) KMT2AMEN1DEGS1TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9364424-B2 Topical cosmetic skin lightening compositions and methods of use thereof STIEFEL LABORATORIES, INC. (US) 2016-06-14 — — US disclosed
US-20160074315-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. 2016-03-17 — — US disclosed
EP-2219600-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2010-08-25 — — EP disclosed
WO-2009067095-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2009-05-28 — — WO disclosed
EP-1602354-B1 Use of polyglutamic acid or its salts MEIJI SEIKA KAISHA (JP) 2008-11-05 — — EP disclosed
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair MEIJI SEIKA KAISHA, LTD. (JP) 2006-07-27 — — US disclosed
US-20060018867-A1 Cosmetic composition and production thereof ICHIMARU PHARCOS CO., LTD 2006-01-26 — — US disclosed
EP-1602354-A1 HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR Meiji Seika Kaisha, Ltd. (JP) 2005-12-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair CUTA, COL14A1, PRKDC NPC1 4845/4885RAB9A 3880/4885KMT2A 998/4885
US-20060018867-A1 Cosmetic composition and production thereof CUTA, PARG, TYR NPC1 3666/4885RAB9A 1846/4885KMT2A 847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback